Drug Therapy

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Holly L. Thacker, MD
Head, Section of Women’s Health, Women’s Health Center; Director, Women’s Health Track, General Internal Medicine Fellowship, The Cleveland Clinic

Address: Holly L. Thacker, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Thacker has indicated that she serves on the speakers’ bureaus of the Pfizer, Wyeth-Ayerst, Eli Lilly, and Merck corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Holly L. Thacker, MD
Head, Section of Women’s Health, Women’s Health Center; Director, Women’s Health Track, General Internal Medicine Fellowship, The Cleveland Clinic

Address: Holly L. Thacker, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Thacker has indicated that she serves on the speakers’ bureaus of the Pfizer, Wyeth-Ayerst, Eli Lilly, and Merck corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Holly L. Thacker, MD
Head, Section of Women’s Health, Women’s Health Center; Director, Women’s Health Track, General Internal Medicine Fellowship, The Cleveland Clinic

Address: Holly L. Thacker, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Thacker has indicated that she serves on the speakers’ bureaus of the Pfizer, Wyeth-Ayerst, Eli Lilly, and Merck corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Jason M. Wolf, MD
Department of Gastroenterology, The Cleveland Clinic

Bret A. Lashner, MD
Director, Center for Inflammatory Bowel Disease, Department of Gastroenterology, The Cleveland Clinic

Address: Bret A. Lashner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Jason M. Wolf, MD
Department of Gastroenterology, The Cleveland Clinic

Bret A. Lashner, MD
Director, Center for Inflammatory Bowel Disease, Department of Gastroenterology, The Cleveland Clinic

Address: Bret A. Lashner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Jason M. Wolf, MD
Department of Gastroenterology, The Cleveland Clinic

Bret A. Lashner, MD
Director, Center for Inflammatory Bowel Disease, Department of Gastroenterology, The Cleveland Clinic

Address: Bret A. Lashner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Maurie Markman, MD
Director, The Cleveland Clinic Taussig Cancer Center; Chairman, Department of Hematology/Medical Oncology, The Lee and Jerome Burkons Research Chair in Oncology, The Cleveland Clinic Foundation

Address: Maurie Markman, MD, The Cleveland Clinic Taussig Cancer Center, R30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195; e-mail [email protected]  

Maurie Markman, MD
Director, The Cleveland Clinic Taussig Cancer Center; Chairman, Department of Hematology/Medical Oncology, The Lee and Jerome Burkons Research Chair in Oncology, The Cleveland Clinic Foundation

Address: Maurie Markman, MD, The Cleveland Clinic Taussig Cancer Center, R30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195; e-mail [email protected]  

Maurie Markman, MD
Director, The Cleveland Clinic Taussig Cancer Center; Chairman, Department of Hematology/Medical Oncology, The Lee and Jerome Burkons Research Chair in Oncology, The Cleveland Clinic Foundation

Address: Maurie Markman, MD, The Cleveland Clinic Taussig Cancer Center, R30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195; e-mail [email protected]  

Emanuel Frisch, MD
Farmington Hills, MI

Emanuel Frisch, MD
Farmington Hills, MI

Emanuel Frisch, MD
Farmington Hills, MI